Know Cancer

or
forgot password

'A Multicentre, Prospective Randomized Study to Assess the Effect When GnRH Antagonist is Started Either on Stimulation Day 1 and Day 6 vs. Conventional GnRH Agonist Long Protocol in Patients With Polycystic Ovary Syndrome Undergoing IVF-ET(in Vitro Fertilization - Embryo Transfer)


Phase 3
20 Years
40 Years
Open (Enrolling)
Female
Infertility, Polycystic Ovary Syndrome

Thank you

Trial Information

'A Multicentre, Prospective Randomized Study to Assess the Effect When GnRH Antagonist is Started Either on Stimulation Day 1 and Day 6 vs. Conventional GnRH Agonist Long Protocol in Patients With Polycystic Ovary Syndrome Undergoing IVF-ET(in Vitro Fertilization - Embryo Transfer)


Inclusion Criteria:



- PCOS patients (diagnosed as 2003 ASRM(The American Society for Reproductive
Medicine)/ESHRE(The European Society of Human Reproduction and Embryology) consensus
meeting guideline)

- age 20-40 years

- patients who have normal uterus

Exclusion Criteria:

- patients who have abnormal thyroid function

- patients who have abnormal prolactin test

- patients who have diabetes, or Cushing's syndrome, or congenital adrenal hyperplasia,
or androgen-producing tumor.

- Patients who reject informed consent

- patients who have experience of adverse events for GnRH agonist, antagonist,
recombinant FSH(follicle-stimulating hormone).

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

number of oocyte retrieved

Outcome Time Frame:

ovum pick up day, At the point of ovum pick-up, we can count how many oocyte was retrieved. So, almost just after ovum pick-up, outcome measure will be possible.

Safety Issue:

No

Authority:

Korea: Institutional Review Board

Study ID:

PCOS_IVF

NCT ID:

NCT01402336

Start Date:

June 2011

Completion Date:

December 2016

Related Keywords:

  • Infertility
  • Polycystic Ovary Syndrome
  • Polycystic ovary syndrome
  • ovulation induction
  • In vitro fertilization-embryo transfer
  • Infertility
  • Polycystic Ovary Syndrome

Name

Location